Table of Contents
Global Generic Active Pharmaceutical Ingredients Sales Market Report 2021
1 Generic Active Pharmaceutical Ingredients Market Overview
1.1 Product Overview and Scope of Generic Active Pharmaceutical Ingredients
1.2 Classification of Generic Active Pharmaceutical Ingredients by Product Category
1.2.1 Global Generic Active Pharmaceutical Ingredients Market Size (Sales) Comparison by Type ( 2016 - 2027)
1.2.2 Global Generic Active Pharmaceutical Ingredients Market Size (Sales) Market Share by Type (Product Category) in 2020
1.2.3 Monoclonal Antibodies
1.2.4 Hormones
1.2.5 Cytokines
1.2.6 Fusion Proteins
1.2.7 Therapeutic Enzymes
1.2.8 Vaccines
1.2.9 Blood Factors
1.3 Global Generic Active Pharmaceutical Ingredients Market by Application/End Users
1.3.1 Global Generic Active Pharmaceutical Ingredients Sales (Volume) and Market Share Comparison by Application ( 2016 - 2027)
1.3.2 Oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Disease
1.3.5 CNS and Neurological Disorders
1.3.6 Endocrinology
1.3.7 Others
1.4 Global Generic Active Pharmaceutical Ingredients Market by Region
1.4.1 Global Generic Active Pharmaceutical Ingredients Market Size (Value) Comparison by Region ( 2016 - 2027)
1.4.2 United States Generic Active Pharmaceutical Ingredients Status and Prospect ( 2016 - 2027)
1.4.3 Europe Generic Active Pharmaceutical Ingredients Status and Prospect ( 2016 - 2027)
1.4.4 China Generic Active Pharmaceutical Ingredients Status and Prospect ( 2016 - 2027)
1.4.5 Japan Generic Active Pharmaceutical Ingredients Status and Prospect ( 2016 - 2027)
1.4.6 Southeast Asia Generic Active Pharmaceutical Ingredients Status and Prospect ( 2016 - 2027)
1.4.7 India Generic Active Pharmaceutical Ingredients Status and Prospect ( 2016 - 2027)
1.5 Global Market Size (Value and Volume) of Generic Active Pharmaceutical Ingredients ( 2016 - 2027)
1.5.1 Global Generic Active Pharmaceutical Ingredients Sales and Growth Rate ( 2016 - 2027)
1.5.2 Global Generic Active Pharmaceutical Ingredients Revenue and Growth Rate ( 2016 - 2027)
2 Global Generic Active Pharmaceutical Ingredients Competition by Players/Suppliers, Type and Application
2.1 Global Generic Active Pharmaceutical Ingredients Market Competition by Players/Suppliers
2.1.1 Global Generic Active Pharmaceutical Ingredients Sales and Market Share of Key Players/Suppliers ( 2016 - 2021)
2.1.2 Global Generic Active Pharmaceutical Ingredients Revenue and Share by Players/Suppliers ( 2016 - 2021)
2.2 Global Generic Active Pharmaceutical Ingredients (Volume and Value) by Type
2.2.1 Global Generic Active Pharmaceutical Ingredients Sales and Market Share by Type ( 2016 - 2021)
2.2.2 Global Generic Active Pharmaceutical Ingredients Revenue and Market Share by Type ( 2016 - 2021)
2.3 Global Generic Active Pharmaceutical Ingredients (Volume and Value) by Region
2.3.1 Global Generic Active Pharmaceutical Ingredients Sales and Market Share by Region ( 2016 - 2021)
2.3.2 Global Generic Active Pharmaceutical Ingredients Revenue and Market Share by Region ( 2016 - 2021)
2.4 Global Generic Active Pharmaceutical Ingredients (Volume) by Application
3 United States Generic Active Pharmaceutical Ingredients (Volume, Value and Sales Price)
3.1 United States Generic Active Pharmaceutical Ingredients Sales and Value ( 2016 - 2021)
3.1.1 United States Generic Active Pharmaceutical Ingredients Sales and Growth Rate ( 2016 - 2021)
3.1.2 United States Generic Active Pharmaceutical Ingredients Revenue and Growth Rate ( 2016 - 2021)
3.1.3 United States Generic Active Pharmaceutical Ingredients Sales Price Trend ( 2016 - 2021)
3.2 United States Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Players ( 2016 - 2021)
3.3 United States Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Type ( 2016 - 2021)
3.4 United States Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Application ( 2016 - 2021)
4 Europe Generic Active Pharmaceutical Ingredients (Volume, Value and Sales Price)
4.1 Europe Generic Active Pharmaceutical Ingredients Sales and Value ( 2016 - 2021)
4.1.1 Europe Generic Active Pharmaceutical Ingredients Sales and Growth Rate ( 2016 - 2021)
4.1.2 Europe Generic Active Pharmaceutical Ingredients Revenue and Growth Rate ( 2016 - 2021)
4.1.3 Europe Generic Active Pharmaceutical Ingredients Sales Price Trend ( 2016 - 2021)
4.2 Europe Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Players ( 2016 - 2021)
4.3 Europe Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Type ( 2016 - 2021)
4.4 Europe Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Application ( 2016 - 2021)
5 China Generic Active Pharmaceutical Ingredients (Volume, Value and Sales Price)
5.1 China Generic Active Pharmaceutical Ingredients Sales and Value ( 2016 - 2021)
5.1.1 China Generic Active Pharmaceutical Ingredients Sales and Growth Rate ( 2016 - 2021)
5.1.2 China Generic Active Pharmaceutical Ingredients Revenue and Growth Rate ( 2016 - 2021)
5.1.3 China Generic Active Pharmaceutical Ingredients Sales Price Trend ( 2016 - 2021)
5.2 China Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Players ( 2016 - 2021)
5.3 China Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Type ( 2016 - 2021)
5.4 China Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Application ( 2016 - 2021)
6 Japan Generic Active Pharmaceutical Ingredients (Volume, Value and Sales Price)
6.1 Japan Generic Active Pharmaceutical Ingredients Sales and Value ( 2016 - 2021)
6.1.1 Japan Generic Active Pharmaceutical Ingredients Sales and Growth Rate ( 2016 - 2021)
6.1.2 Japan Generic Active Pharmaceutical Ingredients Revenue and Growth Rate ( 2016 - 2021)
6.1.3 Japan Generic Active Pharmaceutical Ingredients Sales Price Trend ( 2016 - 2021)
6.2 Japan Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Players ( 2016 - 2021)
6.3 Japan Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Type ( 2016 - 2021)
6.4 Japan Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Application ( 2016 - 2021)
7 Southeast Asia Generic Active Pharmaceutical Ingredients (Volume, Value and Sales Price)
7.1 Southeast Asia Generic Active Pharmaceutical Ingredients Sales and Value ( 2016 - 2021)
7.1.1 Southeast Asia Generic Active Pharmaceutical Ingredients Sales and Growth Rate ( 2016 - 2021)
7.1.2 Southeast Asia Generic Active Pharmaceutical Ingredients Revenue and Growth Rate ( 2016 - 2021)
7.1.3 Southeast Asia Generic Active Pharmaceutical Ingredients Sales Price Trend ( 2016 - 2021)
7.2 Southeast Asia Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Players ( 2016 - 2021)
7.3 Southeast Asia Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Type ( 2016 - 2021)
7.4 Southeast Asia Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Application ( 2016 - 2021)
8 India Generic Active Pharmaceutical Ingredients (Volume, Value and Sales Price)
8.1 India Generic Active Pharmaceutical Ingredients Sales and Value ( 2016 - 2021)
8.1.1 India Generic Active Pharmaceutical Ingredients Sales and Growth Rate ( 2016 - 2021)
8.1.2 India Generic Active Pharmaceutical Ingredients Revenue and Growth Rate ( 2016 - 2021)
8.1.3 India Generic Active Pharmaceutical Ingredients Sales Price Trend ( 2016 - 2021)
8.2 India Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Players ( 2016 - 2021)
8.3 India Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Type ( 2016 - 2021)
8.4 India Generic Active Pharmaceutical Ingredients Sales Volume and Market Share by Application ( 2016 - 2021)
9 Global Generic Active Pharmaceutical Ingredients Players/Suppliers Profiles and Sales Data
9.1 Pfizer, Inc. (U.S.)
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.1.4 Main Business/Business Overview
9.2 Novartis International AG (Switzerland)
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.2.4 Main Business/Business Overview
9.3 Sanofi (France)
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Sanofi (France) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.3.4 Main Business/Business Overview
9.4 Boehringer Ingelheim (Germany)
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.4.4 Main Business/Business Overview
9.5 Bristol - Myers Squibb (U.S.)
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Bristol - Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.5.4 Main Business/Business Overview
9.6 Teva Pharmaceutical Industries Ltd. (Israel)
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.6.4 Main Business/Business Overview
9.7 Eli Lilly and Company (U.S.)
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.7.4 Main Business/Business Overview
9.8 GlaxoSmithKline plc (U.K.)
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.8.4 Main Business/Business Overview
9.9 Merck & Co., Inc. (U.S.)
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.9.4 Main Business/Business Overview
9.10 AbbVie Inc. (U.S.)
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Generic Active Pharmaceutical Ingredients Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin ( 2016 - 2021)
9.10.4 Main Business/Business Overview
10 Generic Active Pharmaceutical Ingredients Maufacturing Cost Analysis
10.1 Generic Active Pharmaceutical Ingredients Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Generic Active Pharmaceutical Ingredients
10.3 Manufacturing Process Analysis of Generic Active Pharmaceutical Ingredients
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Generic Active Pharmaceutical Ingredients Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Generic Active Pharmaceutical Ingredients Major Manufacturers in 2020
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Generic Active Pharmaceutical Ingredients Market Forecast ( 2021 - 2027)
14.1 Global Generic Active Pharmaceutical Ingredients Sales Volume, Revenue and Price Forecast ( 2021 - 2027)
14.1.1 Global Generic Active Pharmaceutical Ingredients Sales Volume and Growth Rate Forecast ( 2021 - 2027)
14.1.2 Global Generic Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast ( 2021 - 2027)
14.1.3 Global Generic Active Pharmaceutical Ingredients Price and Trend Forecast ( 2021 - 2027)
14.2 Global Generic Active Pharmaceutical Ingredients Sales Volume, Revenue and Growth Rate Forecast by Region ( 2021 - 2027)
14.2.1 Global Generic Active Pharmaceutical Ingredients Sales Volume and Growth Rate Forecast by Regions ( 2021 - 2027)
14.2.2 Global Generic Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast by Regions ( 2021 - 2027)
14.2.3 United States Generic Active Pharmaceutical Ingredients Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.4 Europe Generic Active Pharmaceutical Ingredients Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.5 China Generic Active Pharmaceutical Ingredients Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.6 Japan Generic Active Pharmaceutical Ingredients Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.7 Southeast Asia Generic Active Pharmaceutical Ingredients Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.2.8 India Generic Active Pharmaceutical Ingredients Sales Volume, Revenue and Growth Rate Forecast ( 2021 - 2027)
14.3 Global Generic Active Pharmaceutical Ingredients Sales Volume, Revenue and Price Forecast by Type ( 2021 - 2027)
14.3.1 Global Generic Active Pharmaceutical Ingredients Sales Forecast by Type ( 2021 - 2027)
14.3.2 Global Generic Active Pharmaceutical Ingredients Revenue Forecast by Type ( 2021 - 2027)
14.3.3 Global Generic Active Pharmaceutical Ingredients Price Forecast by Type ( 2021 - 2027)
14.4 Global Generic Active Pharmaceutical Ingredients Sales Volume Forecast by Application ( 2021 - 2027)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Generic Active Pharmaceutical Ingredients
Figure Global Generic Active Pharmaceutical Ingredients Sales Volume Comparison (K MT) by Type ( 2016 - 2027)
Figure Global Generic Active Pharmaceutical Ingredients Sales Volume Market Share by Type (Product Category) in 2020
Figure Monoclonal Antibodies Product Picture
Figure Hormones Product Picture
Figure Cytokines Product Picture
Figure Fusion Proteins Product Picture
Figure Therapeutic Enzymes Product Picture
Figure Vaccines Product Picture
Figure Blood Factors Product Picture
Figure Global Generic Active Pharmaceutical Ingredients Sales Comparison (K MT) by Application ( 2016 - 2027)
Figure Global Sales Market Share of Generic Active Pharmaceutical Ingredients by Application in 2020
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Cardiovascular Disease Examples
Table Key Downstream Customer in Cardiovascular Disease
Figure CNS and Neurological Disorders Examples
Table Key Downstream Customer in CNS and Neurological Disorders
Figure Endocrinology Examples
Table Key Downstream Customer in Endocrinology
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Generic Active Pharmaceutical Ingredients Market Size (Million USD) by Regions ( 2016 - 2027)
Figure United States Generic Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Europe Generic Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure China Generic Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Japan Generic Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Southeast Asia Generic Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure India Generic Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Global Generic Active Pharmaceutical Ingredients Sales Volume (K MT) and Growth Rate ( 2016 - 2027)
Figure Global Generic Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Global Market Major Players Generic Active Pharmaceutical Ingredients Sales Volume (K MT) ( 2016 - 2021)
Table Global Generic Active Pharmaceutical Ingredients Sales (K MT) of Key Players/Suppliers ( 2016 - 2021)
Table Global Generic Active Pharmaceutical Ingredients Sales Share by Players/Suppliers ( 2016 - 2021)
Figure 2020 Generic Active Pharmaceutical Ingredients Sales Share by Players/Suppliers
Figure 2020 Generic Active Pharmaceutical Ingredients Sales Share by Players/Suppliers
Figure Global Generic Active Pharmaceutical Ingredients Revenue (Million USD) by Players/Suppliers ( 2016 - 2021)
Table Global Generic Active Pharmaceutical Ingredients Revenue (Million USD) by Players/Suppliers ( 2016 - 2021)
Table Global Generi
